Mentice AB (publ)

$15.40+0.98%(+$0.15)
TickerSpark Score
53/100
Mixed
64
Valuation
35
Profitability
15
Growth
52
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MNTC.ST research report →

52-Week Range54% of range
Low $8.50
Current $15.40
High $21.30

Companywww.mentice.com

Mentice AB (publ) provides endovascular simulation solutions to teaching entities, healthcare systems, and medical device manufacturers. The company operates through Medical Device Industry, Healthcare Systems, and Strategic Alliances segments. It provides software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced and essentials, coronary intermediate, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic artery embolization, radiation safety, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, peripheral angiography, and vascular trauma and cardiac rhythm management, as well as supports interventionalists to transition from transfemoral to transradial access.

CEO
Frans Matthieu Venker
IPO
2019
Employees
131
HQ
Gothenburg, SE

Price Chart

-0.32% · this period
$21.20$15.10$9.00May 16Nov 13May 21

Valuation

Market Cap
$433.14M
P/E
-20.34
P/S
1.51
P/B
3.51
EV/EBITDA
49.21
Div Yield
0.00%

Profitability

Gross Margin
40.31%
Op Margin
-7.76%
Net Margin
-7.42%
ROE
-17.62%
ROIC
-16.04%

Growth & Income

Revenue
$279.09M · -3.87%
Net Income
$-32,334,000 · -75.54%
EPS
$-1.15 · -59.72%
Op Income
$-33,060,000
FCF YoY
-1816.88%

Performance & Tape

52W High
$21.30
52W Low
$8.50
50D MA
$13.40
200D MA
$13.00
Beta
0.64
Avg Volume
15.11K

Get TickerSpark's AI analysis on MNTC.ST

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our MNTC.ST Coverage

We haven't published any research on MNTC.ST yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MNTC.ST Report →

Similar Companies